Obermatt
See Similar Stocks →

CervoMed

NAQ:CRVO · US15713L1098
BiotechnologySmall

360° View

no current rank
Price/Sales48
Price/Earnings3
Price/Book69
Dividend Yield—
Revenue Growth23
Profit Growth91
Capital Growth18
TSR 52w6
Leverage74
Liquidity—
Refinancing15
Combined—
Analyst Opinions100
Pro Holdings21
Opinion Changes11
Market Pulse37

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Employees8
Websitecervomed.com
ISINUS15713L1098
Last UpdateApr 2, 2026
Index & Theme
NeuroscienceCentral Nervous SystemChronic DiseasesNeurologyBiopharmaBiotechnologyHealth CarePharmaceuticalService Industry

Description

CervoMed Inc. (‘CervoMed’), a clinical-stage biotechnology company, focuses on developing treatments for age-related neurologic disorders. The company is focused on the development of its lead drug candidate, neflamapimod, an investigational, orally…

Similar Stocks

The companies this stock is ranked against.

Compare CervoMed with its peers
ACADIA Pharmaceuticals
NSQ:ACAD
80
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Immuneering
NMQ:IMRX
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Eupraxia Pharmaceuticals
TOR:EPRX
—
CountryCanada
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Zura Bio
NAQ:ZURA
56
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Inhibikase Therapeutics
NAQ:IKT
10
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Pyxis Oncology
NSQ:PYXS
49
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →